Comparative Analysis: Autograft vs. Allograft in ACL Reconstruction

Posted on: March 17th, 2026 by Our Team

When someone tears their ACL and needs surgery, one of the biggest decisions is what type of graft to use to rebuild the ligament. A graft is the tissue used to replace the torn ACL. The two main options are an autograft (tissue taken from your own body) or an allograft (donor tissue taken from someone who has passed away). Both options can work, but large medical studies show that the choice of graft can strongly affect how likely the ACL is to fail again in the future.

Some of the strongest data on this topic come from the MOON study (Multicenter Orthopaedic Outcomes Network), which followed thousands of patients who had ACL reconstruction. In this study of 2,488 patients, those who received an allograft had a much higher risk of tearing the new ACL again compared to patients who received an autograft. In fact, allografts failed more than five times as often as autografts. Overall, about 4 out of every 100 patients re-tore their ACL, but the risk was much higher in patients who received donor tissue.

The MOON study also showed that age and activity level are extremely important. Younger patients had a much higher chance of graft failure than older patients. Patients who regularly did high-risk activities such as running, cutting, pivoting, or jumping were also more likely to re-tear the graft. As patients got older, the risk of graft failure steadily decreased. This is why graft choice matters most in younger, more active people.

Other large studies have shown the same pattern. A large Kaiser Permanente registry study of more than 5,500 patients found that donor grafts failed more than four times as often as autografts within the first two years after surgery. Another nationwide study from South Korea that followed more than 140,000 patients also found higher failure rates in patients who received allografts. While the exact numbers differ between studies, the overall message is consistent: allografts fail more often than autografts, especially in younger patients.

An important detail is that this difference changes with age. The studies show that in patients under about 40 years old, particularly those who are active or play sports, allografts have a clearly higher failure rate. However, in patients around 40 years old and older, especially those who are not doing aggressive cutting or pivoting sports, the outcomes between autografts and allografts become much more similar. This does not mean that allografts suddenly become stronger at age 40. Instead, the overall stress placed on the knee and the ACL graft is lower as people get older and tend to move more cautiously. Because the baseline risk of re-tearing an ACL goes down, the difference between graft types matters less.

How donor tissue is prepared also affects results. Some allografts are treated with radiation or chemicals to reduce the risk of infection. Unfortunately, these treatments can weaken the graft. Studies show that irradiated allografts (donor tissue treated with radiation) fail more often than autografts. Non-irradiated allografts do better, but they still do not consistently match the durability of a patient’s own tissue. Many patients are not told how their donor graft was processed, which adds uncertainty to this option.

The difference between graft types becomes even more important in revision ACL surgery (a second ACL reconstruction). Large studies show that patients who receive an autograft during revision surgery are much less likely to tear the graft again compared to those who receive an allograft. Autograft patients also tend to need fewer additional surgeries and are able to return to higher activity levels.

Allografts do have some advantages. They avoid taking tissue from the patient’s own body, which can mean less pain at the harvest site and a shorter surgery. For some patients, especially those who are older and less active, this trade-off may be reasonable. However, when looking at long-term knee health, especially in patients under 40 who want to remain active, autografts are generally more reliable and last longer.

The choice between autograft and allograft should be individualized based on age, activity level, sport goals, and long-term plans. For many younger and athletic patients, using their own tissue offers the best chance of a strong, durable knee. For patients around 40 and older who are not involved in high-risk sports, donor tissue may be an acceptable option when the risks are clearly understood. The goal is not just to recover quickly, but to protect the knee for the long term and reduce the chance of needing another surgery later in life.

Take Home Points:

• The highest level of research in the United States show that allografts fail more often than autografts, especially in younger and active patients.
• Around age 40 and older, especially in less aggressive sports, autografts and allografts can perform more similarly.
• How donor tissue is processed matters and can affect graft strength.
• The best graft choice depends on age, activity level, and long-term goals, not just short-term recovery.